SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-021292
Filing Date
2021-06-01
Accepted
2021-06-01 16:05:49
Documents
1
Period of Report
2021-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6278
  Complete submission text file 0000899243-21-021292.txt   7662
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AXCELLA HEALTH INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Mitchener Stephen (Reporting) CIK: 0001774519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 21985260